You just read:

TheraVida Announces Positive Top-Line Phase 2 Results for Tolenix™ (THVD-201) in Patients with Overactive Bladder and Urge Urinary Incontinence

News provided by

TheraVida, Inc.

Jan 03, 2013, 08:30 EST